Curtana Pharmaceuticals https://validator.w3.org/feed/docs/rss2.html Game On Glio Podcast: A Fireside Chat With Curtana Pharmaceuticals’ Dr. Gregory Stein Santosh Kesari, MD, PhD, FANA, NBPAS Santosh Kesari, MD, PhD, FANA, NBPAS Contact Gregory Stein, MD Science Charles Abernathy Scott Rettig Robert Michel, PhD Frank Del Greco Lawrence J. Trost, PhD, DABT Mark Sorenson, PhD Michelle Rose, PhD Sharon Choe Martin Bexon, MD Timothy Gershon, MD, PhD Gary W. Pace, PhD Martin Simonetti Jann Sarkaria, MD Xiao-Nan Li, MD, PhD Terrence Johns, PhD Peter Dirks, MD, PhD Bryan Day, PhD Curtana Pharmaceuticals Announces Breakthrough in Pediatric Brain Cancer Treatment with Dual Studies Published in Nature Communications Curtana Pharmaceuticals’ CT-179 Overcomes Immunotherapy Resistance in Glioblastoma Study Confirms CT-179 Potentiates Radiation Therapy in Pediatric High-Grade Glioma Models Curtana Pharmaceuticals Signs Development and Manufacturing Agreement with Catalent for Brain Cancer Drug CT-179 Curtana Signs Exclusive Worldwide License Agreement Curtana Pharmaceuticals Awarded $7.6 Million Grant From The Cancer Prevention And Research Institute Of Texas Curtana Pharmaceuticals Awarded NIH Small Business Technology Transfer Grant To Advance Glioblastoma Therapy Martin Simonetti Joins Curtana Board of Directors Gary W. Pace Joins Curtana Pharmaceuticals Board of Directors Curtana Pharmaceuticals Receives Top Honors at the 5th Annual Texas Life Science Forum Curtana Pharmaceuticals Selected to Present at Inaugural University Startups Demo Day in Washington, DC Curtana Pharmaceuticals Granted FDA Orphan Drug Designation for CT-179 for the Treatment of Gliomas Clinical Trials Curtana Pharmaceuticals Successfully Completes Pre-IND Submission for CT-179 for the Treatment of Malignant Gliomas Curtana Pharmaceuticals’ CT-179 Receives Rare Pediatric Disease Designation from the U.S. FDA for the Treatment of Medulloblastoma Abstract Published in Neuro-Oncology Demonstrates Curtana Pharmaceuticals’ CT-179 Prolonged Event-free Survival in an Animal Model of Medulloblastoma Curtana Adds Industry Luminaries to Scientific Advisory Board Home